Exelixis Stock Investor Sentiment

EXEL Stock  USD 35.59  0.87  2.39%   
About 77 percent of Exelixis' institutional investors are selling. The analysis of the overall investor sentiment regarding Exelixis suggests that many traders are terrified. Exelixis' investing sentiment shows overall attitude of investors towards Exelixis.

Panic Vs Confidence

23

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Exelixis' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Exelixis.

Exelixis Historical Sentiment

Although Exelixis' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Exelixis, such as negative comments on social media and news outlets, may cause fear in the market and push Exelixis' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Exelixis.
  

Exelixis Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Exelixis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Exelixis Historical Investor Sentiment

Investor biases related to Exelixis' public news can be used to forecast risks associated with an investment in Exelixis. The trend in average sentiment can be used to explain how an investor holding Exelixis can time the market purely based on public headlines and social activities around Exelixis. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Exelixis' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Exelixis and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Exelixis news discussions. The higher the estimate score, the more favorable the investor's outlook on Exelixis.
a day ago at talkmarkets.com         
3 MFS Mutual Funds For Excellent Returns
news
2 days ago at talkmarkets.com         
Disposition of 16298 shares by Michael Morrissey of Exelixis subject to Rule 16b-3
news
few days ago at simplywall.st         
Is Exelixis, Inc.s Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Simply Wall St News at Macroaxis
few days ago at finance.yahoo.com         
Heres Why Exelixis is a Strong Momentum Stock
Yahoo News
few days ago at zacks.com         
Heres Why Exelixis is a Strong Momentum Stock
zacks News
few days ago at zacks.com         
Techne Up 2.2 percent Since Last Earnings Report Can It Continue?
zacks News
few days ago at zacks.com         
Exelixis Up 10.8 percent Since Last Earnings Report Can It Continue?
zacks News
few days ago at finance.yahoo.com         
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December
Yahoo News
few days ago at investing.com         
Exelixis reiterates Equal Weight rating, stock target amid FDA update
Investing News at Macroaxis
few days ago at zacks.com         
Zacks Investment Ideas feature highlights InterDigital, Futu and Exelixis
zacks News
few days ago at investing.com         
Exelixis EVP Haley Patrick J. sells 352,700 in stock
Investing News at Macroaxis
six days ago at finance.yahoo.com         
End of Year Rally 3 Stocks to Watch
Yahoo News
six days ago at seekingalpha.com         
Exelixis given March 2025 FDA AdCom meeting for Cabometyx sNDA
seekingalpha News
six days ago at businesswire.com         
Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib fo...
businesswire News
six days ago at businesswire.com         
Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib fo...
businesswire News
Far too much social signal, news, headlines, and media speculation about Exelixis that are available to investors today. That information is available publicly through Exelixis media outlets and privately through word of mouth or via Exelixis internal channels. However, regardless of the origin, that massive amount of Exelixis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Exelixis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Exelixis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Exelixis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Exelixis alpha.

Exelixis Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 25000 shares by Hessekiel Jeffrey of Exelixis at 26.38 subject to Rule 16b-3
09/23/2024
2
Disposition of 480000 shares by Michael Morrissey of Exelixis at 24.41 subject to Rule 16b-3
10/01/2024
3
Exelixis earnings beat by 0.13, revenue topped estimates
10/29/2024
4
Have Insiders Sold Exelixis Shares Recently
11/08/2024
5
Disposition of 27224 shares by Peterson Amy C. of Exelixis at 35.05 subject to Rule 16b-3
11/15/2024
6
Disposition of 19381 shares by Haley Patrick J. of Exelixis at 34.41 subject to Rule 16b-3
11/18/2024
7
3 TSX Penny Stocks With Market Caps Over CA30M
11/21/2024
8
Disposition of 10000 shares by Haley Patrick J. of Exelixis at 35.27 subject to Rule 16b-3
11/22/2024
9
Exelixis is a Top-Ranked Value Stock Should You Buy
11/25/2024
10
Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib for the Treatment of Patients with Previously Treated Advanced...
11/26/2024
11
Exelixis reiterates Equal Weight rating, stock target amid FDA update
11/27/2024
12
Heres Why Exelixis is a Strong Momentum Stock
11/29/2024
13
3 MFS Mutual Funds For Excellent Returns
12/02/2024
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
Check out Exelixis Hype Analysis, Exelixis Correlation and Exelixis Performance.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
121.699
Earnings Share
1.55
Revenue Per Share
7.032
Quarterly Revenue Growth
0.143
Return On Assets
0.1281
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.